Prostaglandin receptor EP2 antagonists, derivatives, compositions, and uses related thereto
US9518044B2 · kind B2 · utility
12Cited by
0References
3Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 19, 2012 |
| Grant date | Dec 13, 2016 |
| Priority date | — |
| Expiry date | Jan 1, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D403/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to compounds of Formula IC:
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.